SAGE Logo

Sage Therapeutics, Inc. (SAGE) 

NASDAQ$7.72
Market Cap
$474.63M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
826 of 924
Rank in Industry
471 of 527

SAGE Insider Trading Activity

SAGE Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$00–
Sells
$00–

Related Transactions

No records found

About Sage Therapeutics, Inc.

Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive steroid, which is in Phase III clinical trials for treating PPD, major depressive disorders, treatment resistant disorders, generalized anxiety disorders, and bipolar depression; and SAGE-324, a â€¦

Insider Activity of Sage Therapeutics, Inc.

Over the last 12 months, insiders at Sage Therapeutics, Inc. have bought $0 and sold $0 worth of Sage Therapeutics, Inc. stock.

On average, over the past 5 years, insiders at Sage Therapeutics, Inc. have bought $1.15M and sold $519,413 worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 2,000 shares for transaction amount of $37,279 was made by Barrett Elizabeth (director) on 2023‑08‑09.

List of Insider Buy and Sell Transactions, Sage Therapeutics, Inc.

2023-08-09PurchaseBarrett Elizabethdirector
2,000
0.0032%
$18.64$37,279+2.79%
2023-05-09PurchaseBarrett Elizabethdirector
1,000
0.0017%
$50.50$50,500-58.22%
2023-02-10SaleJONAS JEFFREY Mdirector
11,643
0.0193%
$44.61$519,413-41.07%
2022-11-10PurchaseGreene Barry EPresident and CEO
14,500
0.024%
$34.48$500,022+19.17%
2022-05-05PurchaseGolumbeski George
8,000
0.0136%
$31.45$251,563+26.48%
2021-08-05PurchaseGreene Barry EPresident and CEO
23,640
0.0401%
$43.15$1.02M-10.58%
2021-06-16PurchaseSTARR KEVIN Pdirector
17,842
0.0311%
$56.05$999,983-24.87%
2021-06-16PurchaseGreene Barry EPresident and CEO
8,800
0.0154%
$56.32$495,627-24.87%
2021-06-16PurchaseFRATES JAMES Mdirector
1,810
0.0031%
$55.10$99,735-24.87%
2019-12-09PurchaseRobichaud AlbertChief Scientific Officer
25,000
0.0494%
$64.16$1.6M-16.96%
2019-12-09PurchaseJONAS JEFFREY MPresident & CEO
7,500
0.0148%
$64.20$481,500-16.96%
2019-08-15SaleFRATES JAMES Mdirector
8,000
0.0154%
$160.58$1.28M-58.68%
2019-05-29SaleJONAS JEFFREY MPresident & CEO
1,075
0.0021%
$170.61$183,401-20.75%
2019-05-28SaleJONAS JEFFREY MPresident & CEO
84,661
0.1656%
$174.83$14.8M-20.45%
2019-05-24SaleJONAS JEFFREY MPresident & CEO
40,356
0.0786%
$175.08$7.07M-20.51%
2019-05-23SaleJONAS JEFFREY MPresident & CEO
53,908
0.1047%
$174.51$9.41M-20.45%
2019-05-22SaleCloonan MichaelChief Business Officer
25,000
0.0485%
$175.00$4.38M-20.71%
2019-05-10SaleCook Anne MarieSVP, GC & Secretary
15,000
0.0293%
$166.14$2.49M-15.12%
2019-05-06SaleFRATES JAMES Mdirector
8,000
0.0148%
$162.22$1.3M-17.11%
2019-03-21SalePAUL STEVEN Mdirector
7,879
0.0166%
$161.04$1.27M-1.30%
Total: 87

Insider Historical Profitability

6.8%
STARR KEVIN Pdirector
320659
0.5216%
$2.48M14<0.0001%
Robichaud AlbertChief Scientific Officer
136400
0.2219%
$1.05M26+14.96%
PAUL STEVEN Mdirector
122400
0.1991%
$944,928.00114+46.89%
JONAS JEFFREY Mdirector
121981
0.1984%
$941,693.32310<0.0001%
Greene Barry EPresident and CEO
46940
0.0763%
$362,376.8030<0.0001%

Historical Insider Profitability vs. Competitors

$587,109,125
90
3.17%
$527.16M
$14,527,743
76
38.40%
$447.93M
$84,871,118
57
17.71%
$412.59M
$24,384,691
42
-30.27%
$455.92M
$54,828,550
26
-13.88%
$493.09M

SAGE Institutional Investors: Active Positions

Increased Positions78+37.32%12M+22.92%
Decreased Positions84-40.19%12M-23.18%
New Positions26New6MNew
Sold Out Positions26Sold Out2MSold Out
Total Postitions203-2.87%51M-0.26%

SAGE Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Blackrock, Inc.$35,410.007.95%4.85M-540,196-10.02%2024-12-31
Vanguard Group Inc$35,319.007.93%4.84M-922,280-16.01%2024-12-31
Morgan Stanley$33,539.007.53%4.59M+4M+468.05%2024-12-31
Bellevue Group Ag$32,563.007.31%4.46M00%2024-12-31
Fmr Llc$30,054.006.75%4.12M-1M-21.89%2024-12-31
Caligan Partners Lp$22,284.005%3.05M+3MNew2024-12-31
Rtw Investments, Lp$21,917.004.92%3M-3M-46.31%2024-12-31
Millennium Management Llc$11,854.002.66%1.62M+124,720+8.32%2024-12-31
Acadian Asset Management Llc$11,574.002.6%1.59M+638,575+67.44%2024-12-31
Boothbay Fund Management, Llc$10,136.002.28%1.39M+1MNew2024-12-31

Financial Ratios

Summary
Comparison with Competitors

Analyst Recommendations

Analyst Price Targets

Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
2.79Strong BuyBuyHoldSellStrong SellSAGEHighAverageLowSeries 4